ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Compared to Non-Hispanic White Individuals with Type 2 Diabetes Treated with Empagliflozin (EMPA-AA): Real-World Data

186 views
August 1, 2022
Comments 2
Login to view comments. Click here to Login